This opportunity is no longer accepting applications.
grant PAR-23-097

Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

This grant opportunity seeks to support translational research aimed at understanding mood and psychotic disorders that worsen during menopause, such as depression, anxiety, bipolar disorder, and schizophrenia. It encourages interdisciplinary collaboration to study the neurobiological and behavioral mechanisms of these disorders during menopause. Areas of interest include the interaction betwe…

The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effor…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health
Program: SBIR

Dates

Opportunity Released: January 6, 2023
Open for Submission: January 6, 2023
Submission Deadline: November 5, 2024
Application Window Closes: November 5, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.